Abstract #1867
Combination normobaric oxygen and methylene blue treatment delays the progression of ischemic penumbra into infarct and promotes behavioral recovery
Pavel Rodriguez 1,2 , Jiang Zhao 2 , Brian Milman 3 , Lora Talley Watts 2 , and Timothy Q. Duong 2
1
Department of Radiology, University of Texas
Health Science Center at San Antonio, San Antonio,
Texas, United States,
2
Research
Imaging Institute, University of Texas Health Science
Center at San Antonio, San Antonio, Texas, United
States,
3
School
of Medicine, University of Texas Health Science Center
at San Antonio, Texas, United States
We previously reported that methylene blue (MB) an
energy enhancing and antioxidant reduces infarct
volume in 60-mins and permanent MCAO in rats. This study
investigated the combination therapy of MB and
normobaric oxygen (NBO) treatment in ischemic stroke. We
hypothesized that MB+NBO treatment delays infarct growth
and salvages more tissue than NBO + Vehicle treatment
alone in a 60-min MCAO model in rats and that
longitudinal MB treatment promotes faster motor
functional behavioral recovery.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
